Expanding Options for Relapsed/Refractory HER2+ Metastatic Breast Cancer
EP. 1: Treatment Options in HER2+ Metastatic Breast Cancer
By
Targeted Oncology
July 7th 2020
EP. 2: Trastuzumab Emtansine in HER2+ Breast Cancer
By
Targeted Oncology
July 7th 2020
EP. 3: Options in Breast Cancer After HER2+ Targeted Therapy
By
Targeted Oncology
July 7th 2020
EP. 4: Trastuzumab Deruxtecan in HER2+ Breast Cancer
By
Targeted Oncology
July 7th 2020
EP. 5: Neratinib + Capecitabine in HER2+ Breast Cancer
By
Targeted Oncology
July 7th 2020
EP. 6: Understanding HER2CLIMB Clinical Trial
By
Targeted Oncology
July 7th 2020
EP. 7: Toxicity Management When Using HER2CLIMB Regimen
By
Targeted Oncology
July 7th 2020
EP. 8: Next-Generation Sequencing in HER2+ Breast Cancer
By
Targeted Oncology
July 7th 2020
EP. 9: Newly Approved Agents for HER2+ Breast Cancer
By
Targeted Oncology
July 7th 2020
